{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T18:44:52Z","timestamp":1787942692338,"version":"build-2784847793"},"reference-count":75,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.purol.2013.02.012","type":"journal-article","created":{"date-parts":[[2013,6,17]],"date-time":"2013-06-17T18:31:17Z","timestamp":1371493877000},"page":"674-684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["La maladie de Lapeyronie"],"prefix":"10.1016","volume":"23","author":[{"given":"L.","family":"Ferretti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Faix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Droupy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.purol.2013.02.012_bib0005","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/01.ju.0000053800.62741.fe","article-title":"Peyronie's disease: a review","volume":"169","author":"Gholami","year":"2003","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.purol.2013.02.012_bib0010","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1111\/j.1743-6109.2007.00614.x","article-title":"Peyronie's disease (CME)","volume":"4","author":"Bella","year":"2007","journal-title":"J Sex Med"},{"issue":"6\u00a0Pt\u00a01","key":"10.1016\/j.purol.2013.02.012_bib0015","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1097\/01.ju.0000127744.18878.f1","article-title":"Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening","volume":"171","author":"Mulhall","year":"2004","journal-title":"J Urol"},{"issue":"11","key":"10.1016\/j.purol.2013.02.012_bib0020","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1111\/j.1743-6109.2010.02062.x","article-title":"Summary of the recommendations on sexual dysfunctions in men","volume":"7","author":"Montorsi","year":"2010","journal-title":"J Sex Med"},{"issue":"3","key":"10.1016\/j.purol.2013.02.012_bib0025","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1743-6109.2009.01655.x","article-title":"Peyronie's disease following radical prostatectomy: incidence and predictors","volume":"7","author":"Tal","year":"2010","journal-title":"J Sex Med"},{"issue":"3","key":"10.1016\/j.purol.2013.02.012_bib0030","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4321\/S0004-06142007000300021","article-title":"The natural history of Peyronie's disease","volume":"60","author":"Grasso","year":"2007","journal-title":"Arch Esp Urol"},{"issue":"1","key":"10.1016\/j.purol.2013.02.012_bib0035","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.eururo.2006.05.002","article-title":"Alterations in the transforming growth factor (TGF)-beta pathway as a potential factor in the pathogenesis of Peyronie's disease","volume":"51","author":"Haag","year":"2007","journal-title":"Eur Urol"},{"issue":"Suppl.\u00a05","key":"10.1016\/j.purol.2013.02.012_bib0040","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1038\/sj.ijir.3901082","article-title":"Expanding the paradigm for plaque development in Peyronie's disease","volume":"15","author":"Mulhall","year":"2003","journal-title":"Int J Impot Res"},{"issue":"2","key":"10.1016\/j.purol.2013.02.012_bib0045","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1743-6109.2008.01104.x","article-title":"Experimental models of Peyronie's disease. Implications for new therapies","volume":"6","author":"Gonzalez-Cadavid","year":"2009","journal-title":"J Sex Med"},{"issue":"6","key":"10.1016\/j.purol.2013.02.012_bib0050","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0022-5347(06)00270-9","article-title":"An analysis of the natural history of Peyronie's disease","volume":"175","author":"Mulhall","year":"2006","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.purol.2013.02.012_bib0055","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.ijir.3900874","article-title":"Peyronie's disease cell culture models: phenotypic, genotypic and functional analyses","volume":"14","author":"Mulhall","year":"2002","journal-title":"Int J Impot Res"},{"issue":"2","key":"10.1016\/j.purol.2013.02.012_bib0060","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.ijir.3901183","article-title":"Peyronie's disease fibroblasts demonstrate tumorigenicity in the severe combined immunodeficient (SCID) mouse model","volume":"16","author":"Mulhall","year":"2004","journal-title":"Int J Impot Res"},{"issue":"2","key":"10.1016\/j.purol.2013.02.012_bib0065","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/00005392-200102000-00016","article-title":"Basic fibroblast growth factor expression in Peyronie's disease","volume":"165","author":"Mulhall","year":"2001","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.purol.2013.02.012_bib0070","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.urology.2005.01.010","article-title":"Peyronie's disease associated with increase in plasminogen activator inhibitor in fibrotic plaque","volume":"65","author":"Davila","year":"2005","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.purol.2013.02.012_bib0075","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2605.2007.00780.x","article-title":"Repeated intratunical injection of adenovirus expressing transforming growth factor-beta1\u00a0in a rat induces penile curvature with tunical fibrotic plaque: a useful model for the study of Peyronie's disease","volume":"31","author":"Piao","year":"2008","journal-title":"Int J Androl"},{"issue":"1","key":"10.1016\/j.purol.2013.02.012_bib0080","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/j.1939-4640.1998.tb02469.x","article-title":"Transforming growth factor-beta1 (TGF-beta1) in penile and prostate growth in the rat during sexual maturation","volume":"19","author":"Gelman","year":"1998","journal-title":"J Androl"},{"issue":"5","key":"10.1016\/j.purol.2013.02.012_bib0085","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1111\/j.1743-6109.2010.01749.x","article-title":"Pentoxifylline attenuates transforming growth factor-beta1-stimulated elastogenesis in human tunica albuginea-derived fibroblasts. Part 2: Interference in a TGF-beta1\/Smad-dependent mechanism and downregulation of AAT1","volume":"7","author":"Lin","year":"2010","journal-title":"J Sex Med"},{"issue":"6","key":"10.1016\/j.purol.2013.02.012_bib0090","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1111\/j.1743-6109.2010.01790.x","article-title":"Pentoxifylline attenuates transforming growth factor-beta1-stimulated collagen deposition and elastogenesis in human tunica albuginea-derived fibroblasts. Part 1: Impact on extracellular matrix","volume":"7","author":"Shindel","year":"2010","journal-title":"J Sex Med"},{"issue":"4","key":"10.1016\/j.purol.2013.02.012_bib0095","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0022-5347(01)64223-X","article-title":"Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression","volume":"158","author":"El-Sakka","year":"1997","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.purol.2013.02.012_bib0100","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0006-291X(02)00765-9","article-title":"Upregulation of monocyte chemoattractant protein 1\u00a0and effects of transforming growth factor-beta 1\u00a0in Peyronie's disease","volume":"295","author":"Lin","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.purol.2013.02.012_bib0105","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/sj.ijir.3901170","article-title":"Chromosomal instability is demonstrated by fibroblasts derived from the tunica of men with Peyronie's disease","volume":"16","author":"Mulhall","year":"2004","journal-title":"Int J Impot Res"},{"issue":"4","key":"10.1016\/j.purol.2013.02.012_bib0110","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1089-8603(02)00124-6","article-title":"Effect of nitric oxide on the differentiation of fibroblasts into myofibroblasts in the Peyronie's fibrotic plaque and in its rat model","volume":"7","author":"Vernet","year":"2002","journal-title":"Nitric Oxide"},{"issue":"1","key":"10.1016\/j.purol.2013.02.012_bib0115","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00345-008-0320-x","article-title":"Upregulation of mRNA expression of MCP-1\u00a0by TGF-beta1\u00a0in fibroblast cells from Peyronie's disease","volume":"27","author":"Szardening-Kirchner","year":"2009","journal-title":"World J Urol"},{"issue":"2","key":"10.1016\/j.purol.2013.02.012_bib0120","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ajmg.1320120213","article-title":"Peyronie's disease: a newly recognized autosomal-dominant trait","volume":"12","author":"Bias","year":"1982","journal-title":"Am J Med Genet"},{"issue":"Suppl.\u00a04","key":"10.1016\/j.purol.2013.02.012_bib0125","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1038\/sj.ijir.3900591","article-title":"The genetics and immunology of Peyronie's disease","volume":"12","author":"Noss","year":"2000","journal-title":"Int J Impot Res"},{"issue":"4\u00a0Pt\u00a01","key":"10.1016\/j.purol.2013.02.012_bib0130","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/01.ju.0000076488.89748.e1","article-title":"Prospective analysis of HLA classes I and II antigen frequency in patients with Peyronie's disease","volume":"170","author":"Hauck","year":"2003","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.purol.2013.02.012_bib0135","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0022-5347(17)54302-5","article-title":"Non-association of Peyronie's disease with HLA B7\u00a0cross-reactive antigens","volume":"127","author":"Leffell","year":"1982","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.purol.2013.02.012_bib0140","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/S0022-5347(01)65579-4","article-title":"Peyronie's disease is associated with an HLA class II antigen, HLA-DQ5, implying an autoimmune etiology","volume":"156","author":"Nachtsheim","year":"1996","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.purol.2013.02.012_bib0145","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0022-5347(17)32828-8","article-title":"Increased serum levels of anti-elastin antibodies in patients with Peyronie's disease","volume":"152","author":"Stewart","year":"1994","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.purol.2013.02.012_bib0150","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1399-0039.1991.tb02021.x","article-title":"HLA association of idiopathic Peyronie's disease: an indication of autoimmune phenomena in etiopathogenesis?","volume":"38","author":"Rompel","year":"1991","journal-title":"Tissue Antigens"},{"issue":"6","key":"10.1016\/j.purol.2013.02.012_bib0155","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1095\/biolreprod.105.041038","article-title":"Evidence that osteogenic progenitor cells in the human tunica albuginea may originate from stem cells: implications for Peyronie disease","volume":"73","author":"Vernet","year":"2005","journal-title":"Biol Reprod"},{"issue":"9","key":"10.1016\/j.purol.2013.02.012_bib0160","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1046\/j.1464-410X.2003.04224.x","article-title":"Fibrin as an inducer of fibrosis in the tunica albuginea of the rat: a new animal model of Peyronie's disease","volume":"91","author":"Davila","year":"2003","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.purol.2013.02.012_bib0165","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1464-410x.1998.00529.x","article-title":"Histological and ultrastructural alterations in an animal model of Peyronie's disease","volume":"81","author":"El-Sakka","year":"1998","journal-title":"Br J Urol"},{"issue":"6","key":"10.1016\/j.purol.2013.02.012_bib0380","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ijir.2011.36","article-title":"Rat as an animal model for Peyronie's disease research: a review of current methods and the peer-reviewed literature","volume":"23","author":"Chung","year":"2011","journal-title":"Int J Impot Res"},{"issue":"2","key":"10.1016\/j.purol.2013.02.012_bib0175","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.purol.2011.06.009","article-title":"Evaluation clinique et paraclinique de la maladie de Lapeyronie: place des questionnaires et du pharmaco-doppler penien [Clinical and para-clinical assessment of Peyronie's disease: place of questionnaires and penile duplex ultrasound]","volume":"22","author":"Muyshondt","year":"2012","journal-title":"Prog Urol"},{"issue":"6","key":"10.1016\/j.purol.2013.02.012_bib0180","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0022-5347(17)39746-X","article-title":"The natural history of Peyronie's disease","volume":"144","author":"Gelbard","year":"1990","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.purol.2013.02.012_bib0185","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.eururo.2006.02.059","article-title":"A critical analysis of nonsurgical treatment of Peyronie's disease","volume":"49","author":"Hauck","year":"2006","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.purol.2013.02.012_bib0190","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1046\/j.1464-410X.2003.04134.x","article-title":"Combined treatment with vitamin E and colchicine in the early stages of Peyronie's disease","volume":"91","author":"Prieto Castro","year":"2003","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.purol.2013.02.012_bib0195","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2164\/jandrol.108.006221","article-title":"Medical management of Peyronie's disease","volume":"30","author":"Hellstrom","year":"2009","journal-title":"J Androl"},{"issue":"6","key":"10.1016\/j.purol.2013.02.012_bib0200","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/S0022-5347(05)68087-1","article-title":"Tamoxifen versus placebo in the treatment of Peyronie's disease","volume":"162","author":"Teloken","year":"1999","journal-title":"J Urol"},{"issue":"9","key":"10.1016\/j.purol.2013.02.012_bib0205","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1046\/j.1464-410X.2002.02738.x","article-title":"Oral propionyl-l-carnitine and intraplaque verapamil in the therapy of advanced and resistant Peyronie's disease","volume":"89","author":"Cavallini","year":"2002","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.purol.2013.02.012_bib0210","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.eururo.2004.12.022","article-title":"Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie's disease: a prospective, placebo-controlled, randomized study","volume":"47","author":"Weidner","year":"2005","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.purol.2013.02.012_bib0385","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/aja.2010.117","article-title":"Pentoxifylline treatment and penile calcifications in men with Peyronie's disease","volume":"13","author":"Smith","year":"2011","journal-title":"Asian J Androl"},{"issue":"1","key":"10.1016\/j.purol.2013.02.012_bib0220","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1743-6109.2011.02519.x","article-title":"Combination of penile traction, intralesional verapamil, and oral therapies for Peyronie's disease","volume":"9","author":"Abern","year":"2011","journal-title":"J Sex Med"},{"issue":"7","key":"10.1016\/j.purol.2013.02.012_bib0225","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1111\/j.1743-6109.2010.01850.x","article-title":"The management of Peyronie's disease: evidence-based 2010\u00a0guidelines","volume":"7","author":"Ralph","year":"2010","journal-title":"J Sex Med"},{"issue":"1","key":"10.1016\/j.purol.2013.02.012_bib0230","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0022-5347(17)35998-0","article-title":"Collagenase versus placebo in the treatment of Peyronie's disease: a double-blind study","volume":"149","author":"Gelbard","year":"1993","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.purol.2013.02.012_bib0235","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1743-6109.2007.00651.x","article-title":"The use of intralesional clostridial collagenase injection therapy for Peyronie's disease: a prospective, single-center, non-placebo-controlled study","volume":"5","author":"Jordan","year":"2008","journal-title":"J Sex Med"},{"issue":"5","key":"10.1016\/j.purol.2013.02.012_bib0240","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.urology.2007.01.080","article-title":"Open preliminary randomized prospective clinical trial of efficacy and safety of three different verapamil dilutions for intraplaque therapy of Peyronie's disease","volume":"69","author":"Cavallini","year":"2007","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.purol.2013.02.012_bib0245","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.urology.2007.02.042","article-title":"Intralesional verapamil prevents the progression of Peyronie's disease","volume":"69","author":"Bennett","year":"2007","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.purol.2013.02.012_bib0250","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11255-009-9522-4","article-title":"Effect of intralesional verapamil for treatment of Peyronie's disease: a randomized single-blind, placebo-controlled study","volume":"41","author":"Shirazi","year":"2009","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"10.1016\/j.purol.2013.02.012_bib0255","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0022-5347(06)00517-9","article-title":"Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's disease","volume":"176","author":"Hellstrom","year":"2006","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.purol.2013.02.012_bib0260","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.urology.2005.11.005","article-title":"Effect of intralesional interferon-alpha 2b combined with oral vitamin E for treatment of early stage Peyronie's disease: a randomized and prospective study","volume":"67","author":"Inal","year":"2006","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.purol.2013.02.012_bib0265","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1745-7262.2006.00138.x","article-title":"Extracorporeal shockwave therapy for Peyronie's disease: an alternative treatment?","volume":"8","author":"Poulakis","year":"2006","journal-title":"Asian J Androl"},{"issue":"11","key":"10.1016\/j.purol.2013.02.012_bib0270","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1089\/end.2006.20.880","article-title":"Long-term results of extracorporeal shockwave therapy for Peyronie's disease","volume":"20","author":"Srirangam","year":"2006","journal-title":"J Endourol"},{"issue":"2","key":"10.1016\/j.purol.2013.02.012_bib0275","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1089\/end.2006.20.135","article-title":"Extracorporeal shockwave therapy for Peyronie's disease: who benefits?","volume":"20","author":"Taylor","year":"2006","journal-title":"J Endourol"},{"issue":"2","key":"10.1016\/j.purol.2013.02.012_bib0280","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.eururo.2009.05.012","article-title":"A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie's disease","volume":"56","author":"Palmieri","year":"2009","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.purol.2013.02.012_bib0285","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.eururo.2007.06.032","article-title":"The impact of shock wave therapy at varied energy and dose levels on functional and structural changes in erectile tissue","volume":"53","author":"Muller","year":"2008","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.purol.2013.02.012_bib0290","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11255-008-9408-x","article-title":"The effectiveness of transdermal electromotive administration with verapamil and dexamethasone in the treatment of Peyronie's disease","volume":"41","author":"Tuygun","year":"2009","journal-title":"Int Urol Nephrol"},{"issue":"4\u00a0Pt 1","key":"10.1016\/j.purol.2013.02.012_bib0295","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1743-6109.2007.00539.x","article-title":"Comment on \u201cTopical verapamil HCL, topical trifluoroperazine, and topical magnesium sulfate for the treatment of Peyronie's disease\u2013a placebo-controlled pilot study\u201d","volume":"4","author":"Levine","year":"2007","journal-title":"J Sex Med"},{"issue":"6","key":"10.1016\/j.purol.2013.02.012_bib0300","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/j.1743-6109.2008.00814.x","article-title":"Penile traction therapy for treatment of Peyronie's disease: a single-center pilot study","volume":"5","author":"Levine","year":"2008","journal-title":"J Sex Med"},{"issue":"1","key":"10.1016\/j.purol.2013.02.012_bib0305","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ijrobp.2005.06.009","article-title":"Results of radiotherapy for Peyronie's disease","volume":"64","author":"Niewald","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.purol.2013.02.012_bib0310","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0022-5347(17)63751-0","article-title":"Congenital curvature of the phallus: report of three cases with description of corrective operation","volume":"93","author":"Nesbit","year":"1965","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.purol.2013.02.012_bib0315","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/01.ju.0000147160.53124.1a","article-title":"The Nesbit operation for penile curvature: an easy and effective technical modification","volume":"173","author":"Rolle","year":"2005","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.purol.2013.02.012_bib0320","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/S0022-5347(01)66862-9","article-title":"The Nesbit operation for Peyronie's disease: 16-year experience","volume":"154","author":"Ralph","year":"1995","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.purol.2013.02.012_bib0325","first-page":"248","article-title":"Surgical therapy of Peyronie's disease","volume":"50","author":"Hauck","year":"2006","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.purol.2013.02.012_bib0330","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1445-2197.1988.tb01043.x","article-title":"Experience with the Nesbit procedure in the treatment of penile curvature","volume":"58","author":"Watters","year":"1988","journal-title":"Aust N Z J Surg"},{"issue":"4","key":"10.1016\/j.purol.2013.02.012_bib0335","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(17)51407-X","article-title":"The Nesbit procedure for Peyronie's disease","volume":"130","author":"Benson","year":"1983","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.purol.2013.02.012_bib0340","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11255-011-9976-z","article-title":"Plication corporoplasty versus Nesbit operation for the correction of congenital penile curvature. A long-term follow-up","volume":"44","author":"Leonardo","year":"2011","journal-title":"Int Urol Nephrol"},{"issue":"6","key":"10.1016\/j.purol.2013.02.012_bib0345","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.annemergmed.2005.05.028","article-title":"Out-of-hospital pediatric cardiac arrest: an epidemiologic review and assessment of current knowledge","volume":"46","author":"Donoghue","year":"2005","journal-title":"Ann Emerg Med"},{"issue":"2","key":"10.1016\/j.purol.2013.02.012_bib0350","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.juro.2006.09.051","article-title":"Complications of porcine small intestine submucosa graft for Peyronie's disease","volume":"177","author":"Breyer","year":"2007","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.purol.2013.02.012_bib0355","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/j.juro.2007.08.044","article-title":"Use of small intestinal submucosa graft for the surgical management of Peyronie's disease","volume":"178","author":"Knoll","year":"2007","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.purol.2013.02.012_bib0360","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ijir.2010.28","article-title":"Medium-term follow-up of plaque incision and porcine small intestinal submucosal grafting for Peyronie's disease","volume":"22","author":"Staerman","year":"2010","journal-title":"Int J Impot Res"},{"issue":"4","key":"10.1016\/j.purol.2013.02.012_bib0365","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0022-5347(17)32519-3","article-title":"A new treatment for Peyronie's disease: modeling the penis over an inflatable penile prosthesis","volume":"152","author":"Wilson","year":"1994","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.purol.2013.02.012_bib0370","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1743-6109.04046.x","article-title":"Penile prosthetic surgery for Peyronie's disease: defining the need for intraoperative adjuvant maneuvers","volume":"1","author":"Mulhall","year":"2004","journal-title":"J Sex Med"},{"issue":"1","key":"10.1016\/j.purol.2013.02.012_bib0375","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1743-6109.2011.02509.x","article-title":"Simultaneous penile lengthening and penile prosthesis implantation in patients with Peyronie's disease, refractory erectile dysfunction, and severe penile shortening","volume":"9","author":"Sansalone","year":"2012","journal-title":"J Sex Med"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708713001620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708713001620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:23:09Z","timestamp":1761114189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708713001620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":75,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1166708713001620"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2013.02.012","relation":{},"ISSN":["1166-7087"],"issn-type":[{"value":"1166-7087","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"La maladie de Lapeyronie","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2013.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}